Q Urological Corp. is preparing to bring an FDA-approved pediatric ureteral stent to market, according to a Mass High Tech report.
pAguaMedicina is a pediatric hydrogel ureteral stent that connects the urethra to the bladder.
Q Urological intends to bring pAguaMedicina to market before the end of the year, according to the report.
Q Urological Corp. is headquartered in Woburn, Mass.
Related Articles on New Technology:
Eye Implant Allows Blind Woman to See Light
Four TN Medical Startups Receive $100K in Funding
Zynex Receives FDA Clearance for Female Urinary Incontinence Device